Growth Metrics

Bio-Techne (TECH) Enterprise Value Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.16%
Dec 31, 2025 4.37%
Sep 30, 2025 25.36%
Jun 30, 2025 -2.12%
Mar 31, 2025 3.19%
Dec 31, 2024 -33.26%
Sep 30, 2024 -16.88%
Jun 30, 2024 18.15%
Mar 31, 2024 7.56%
Dec 31, 2023 31.06%
Sep 30, 2023 18.18%
Jun 30, 2023 20.32%
Mar 31, 2023 32.31%
Dec 31, 2022 29.59%
Sep 30, 2022 10.72%
Jun 30, 2022 -10.97%
Mar 31, 2022 13.27%
Dec 31, 2021 -1.98%
Sep 30, 2021 20.85%
Jun 30, 2021 17.57%
Mar 31, 2021 -2.55%
Dec 31, 2020 -12.32%
Sep 30, 2020 -81.42%
Jun 30, 2020 -107.91%
Mar 31, 2020 -46.03%
Dec 31, 2019 -55.85%
Sep 30, 2019 3.24%
Jun 30, 2019 28.31%
Mar 31, 2019 -1.34%
Dec 31, 2018 3.60%
Sep 30, 2018 -33.40%
Jun 30, 2018 -15.24%
Mar 31, 2018 -55.28%
Dec 31, 2017 -64.13%
Sep 30, 2017 -0.62%
Jun 30, 2017 -64.57%
Mar 31, 2017 -34.32%
Dec 31, 2016 14.50%
Sep 30, 2016 -39.77%
Jun 30, 2016 13.60%
Mar 31, 2016 47.12%
Dec 31, 2015 17.31%
Sep 30, 2015 33.29%
Jun 30, 2015 69.47%
Mar 31, 2015 27.34%
Dec 31, 2014 25.11%
Sep 30, 2014 29.18%
Jun 30, 2014 -9.14%
Mar 31, 2014 29.64%
Dec 31, 2013 34.69%
Sep 30, 2013 32.36%
Jun 30, 2013 -23.77%
Mar 31, 2013 -42.47%
Dec 31, 2012 -107.69%
Sep 30, 2012 -104.77%
Jun 30, 2012 -91.02%
Mar 31, 2012 -2.67%
Dec 31, 2011 29.31%
Sep 30, 2011 22.75%
Jun 30, 2011 -1.44%
Mar 31, 2011 -97.62%
Dec 31, 2010 0.35%
Sep 30, 2010 1.21%
Jun 30, 2010 13.75%